Literature DB >> 10077661

Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals.

A de Paiva1, F A Meunier, J Molgó, K R Aoki, J O Dolly.   

Abstract

Blockade of acetylcholine release by botulinum neurotoxin type A at the neuromuscular junction induces the formation of an extensive network of nerve-terminal sprouts. By repeated in vivo imaging of N-(3-triethyl ammonium propyl)-4-(4-(dibutylamino)styryl) pyridinium dibromide uptake into identified nerve endings of the mouse sternomastoid muscle after a single intramuscular injection of the toxin, inhibition of stimulated uptake of the dye at the terminals was detected within a few days, together with an increase in staining of the newly formed sprouts. After 28 days, when nerve stimulation again elicited muscle contraction, regulated vesicle recycling occurred only in the sprouts [shown to contain certain soluble N-ethylmaleimide-sensitive factor attachment proteins (SNAREs) and to abut acetylcholine receptors] and not at the parent terminals. Therefore, only these sprouts could be responsible for nerve-muscle transmission at this time. However, a second, distinct phase of the rehabilitation process followed with a return of vesicle turnover to the original terminals, accompanied by an elimination of the by then superfluous sprouts. This extension and later removal of "functional" sprouts indicate their fundamental importance in the repair of paralyzed endplates, a finding with ramifications for the vital process of nerve regeneration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10077661      PMCID: PMC15919          DOI: 10.1073/pnas.96.6.3200

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Neurotransmitter release and synaptic vesicle recycling.

Authors:  F Valtorta; R Fesce; F Grohovaz; C Haimann; W P Hurlbut; N Iezzi; F Torri Tarelli; A Villa; B Ceccarelli
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

2.  In vivo visualization of the growth of pre- and postsynaptic elements of neuromuscular junctions in the mouse.

Authors:  R J Balice-Gordon; J W Lichtman
Journal:  J Neurosci       Date:  1990-03       Impact factor: 6.167

3.  Neurotrophin regulation of cortical dendritic growth requires activity.

Authors:  A K McAllister; L C Katz; D C Lo
Journal:  Neuron       Date:  1996-12       Impact factor: 17.173

4.  An electron microscopic study of the changes induced by botulinum toxin in the motor end-plates of slow and fast skeletal muscle fibres of the mouse.

Authors:  L W Duchen
Journal:  J Neurol Sci       Date:  1971-09       Impact factor: 3.181

5.  Mechanisms of postsynaptic plasticity: remodeling of the junctional acetylcholine receptor cluster induced by motor nerve terminal outgrowth.

Authors:  W C Yee; A Pestronk
Journal:  J Neurosci       Date:  1987-07       Impact factor: 6.167

Review 6.  Synaptic plasticity in the mammalian central nervous system.

Authors:  N Tsukahara
Journal:  Annu Rev Neurosci       Date:  1981       Impact factor: 12.449

7.  Nerve growth in botulinum toxin poisoned muscles.

Authors:  R L Holland; M C Brown
Journal:  Neuroscience       Date:  1981       Impact factor: 3.590

8.  In vivo visualization of pre- and postsynaptic changes during synapse elimination in reinnervated mouse muscle.

Authors:  M M Rich; J W Lichtman
Journal:  J Neurosci       Date:  1989-05       Impact factor: 6.167

9.  Fluorescent probes that stain living nerve terminals.

Authors:  L Magrassi; D Purves; J W Lichtman
Journal:  J Neurosci       Date:  1987-04       Impact factor: 6.167

10.  Visualization of neuromuscular junctions over periods of several months in living mice.

Authors:  J W Lichtman; L Magrassi; D Purves
Journal:  J Neurosci       Date:  1987-04       Impact factor: 6.167

View more
  129 in total

Review 1.  Botulinum toxin in clinical practice.

Authors:  J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

2.  Functional end-plate recovery in long-term botulinum toxin therapy of hemifacial spasm: a nerve conduction study.

Authors:  C Butera; R Guerriero; S Amadio; D Ungaro; H Tesfaghebriel; F Bianchi; G Comi; U Del Carro
Journal:  Neurol Sci       Date:  2012-02-25       Impact factor: 3.307

Review 3.  Botulinum toxin for the treatment of movement disorders.

Authors:  Mary Ann Thenganatt; Stanley Fahn
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

4.  [Pharmacology of botulinum toxin drugs].

Authors:  D Dressler
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

5.  Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism.

Authors:  Callista B Harper; Sally Martin; Tam H Nguyen; Shari J Daniels; Nickolas A Lavidis; Michel R Popoff; Gordana Hadzic; Anna Mariana; Ngoc Chau; Adam McCluskey; Phillip J Robinson; Frederic A Meunier
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

Review 6.  Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity.

Authors:  Andrea Santamato; Francesco Panza
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

Review 7.  Phenomenology, genetics, and CNS network abnormalities in laryngeal dystonia: A 30-year experience.

Authors:  Andrew Blitzer; Mitchell F Brin; Kristina Simonyan; Laurie J Ozelius; Steven J Frucht
Journal:  Laryngoscope       Date:  2017-12-08       Impact factor: 3.325

8.  The Use of Botulinum Toxin Type A in Headache Treatment.

Authors:  Ninan T. Mathew; Alex O. Kaup
Journal:  Curr Treat Options Neurol       Date:  2002-09       Impact factor: 3.598

9.  The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles.

Authors:  A M O Bakheit; N V Fedorova; A A Skoromets; S L Timerbaeva; B B Bhakta; L Coxon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

Review 10.  Therapeutic use of botulinum toxin in migraine: mechanisms of action.

Authors:  Roshni Ramachandran; Tony L Yaksh
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.